Literature DB >> 15168689

Thiomersal in vaccines: a regulatory perspective WHO Consultation, Geneva, 15-16 April 2002.

I Knezevic1, E Griffiths, F Reigel, R Dobbelaer.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15168689     DOI： 10.1016/j.vaccine.2003.11.051

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  3 in total

Review 1.  Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease.

Authors:  Mark Bigham; Ray Copes
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines.

Authors:  José G Dórea
Journal:  Neurochem Res       Date:  2011-02-25       Impact factor: 4.414

3.  Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal.

Authors:  Thomas M Burbacher; Danny D Shen; Noelle Liberato; Kimberly S Grant; Elsa Cernichiari; Thomas Clarkson
Journal:  Environ Health Perspect       Date:  2005-08       Impact factor: 9.031
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.